Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats

doi:10.1016/0006-8993(94)01399-3

Brain Research

Volume 671, Issue 2, 13 February 1995, Pages 329-332

https://doi.org/10.1016/0006-8993(94)01399-3 Get rights and content

Abstract

The variations of Acetylcholine (ACh) release in the cerebral cortex and dorsal hippocampus were monitored by microdialysis during the electroencephalographically recorded sleep-waking cycle in freely moving cats. The results show a state-dependent variation in ACh output in both the cortex and the hippocampus. ACh release increased by approximately 100% during quiet waking (QW) and by 175% during active waking (AW) as referred to slow wave sleep (SWS) baseline. In contrast, a clear difference between the two areas was observed during REM sleep. During this stage ACh release in the cortex reached approximately the same values observed during QW, while in the hippocampus ACh release rose to about 4-fold the level obtained during SWS or twice that of QW. The results support the idea that the increase in ACh release in the cortex reflects the desynchronized EEG of wakefulness and REM sleep, while the marked increase of ACh during REM in the hippocampus may be related to the sustained theta activity in this area.

References (18)

BlandB.H.
The physiology and the pharmacology of hippocampal formation theta rhythms
Prog. Neurobiol.
(1986)
DamsmaG. et al.
A microdialysis and automated on-line analysis approach to study central cholinergic transmission in vivo
HernandezL. et al.
A small, removable microdialysis probe
Life Sci.
(1986)
KametaniH. et al.
Alterations in acetylcholine release in the rat hippocampus during sleep-wakefulness detected by intracerebral dialysis
Life Sci.
(1990)
KempI.R. et al.
The relation of hippocampal theta activity to arousal, attentive behaviour and somato-motor movements in unrestrained cats
Brain Res.
(1975)
KodamaT. et al.
Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brainstem
Neurosci. Lett.
(1990)
KodamaT. et al.
Enhancement of acetylcholine release during REM sleep in caudomedial medulla as measured by in vivo microdyalisis
Brain Res.
(1992)
MesulamM. et al.
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature
Neuroscience
(1983)
MaruE. et al.
Effects of median raphe nucleus lesion on hippocampal EEG in the freely moving rat
Brain Res.
(1979)

There are more references available in the full text version of this article.

Cited by (421)

Functions and mechanisms of adenosine and its receptors in sleep regulation
2024, Sleep Medicine
Sleep is a natural and recurring state of life. Long-term insomnia can lead to physical and mental fatigue, inattention, memory loss, anxiety, depression and other symptoms, imposing immense public health and economic burden worldwide. The sleep and awakening regulation system is composed of many nerve nuclei and neurotransmitters in the brain, and it forms a neural network that interacts and restricts each other to regulate the occurrence and maintenance of sleep-wake. Adenosine (AD) is a neurotransmitter in the central nervous system and a driver of sleep. Meanwhile, the functions and mechanisms underlying sleep-promoting effects of adenosine and its receptors are still not entirely clear. However, in recent years, the increasing evidence indicated that adenosine can promote sleep through inhibiting arousal system and activating sleep-promoting system. At the same time, astrocyte-derived adenosine in modulating sleep homeostasis and sleep loss-induced related cognitive and memory deficits plays an important role. This review, therefore, summarizes the current research on the functions and possible mechanisms of adenosine and its receptors in the regulation of sleep and homeostatic control of sleep. Understanding these aspects will provide us better ideas on clinical problems such as insomnia, hypersomnia and other sleep disorders.
Acetylcholine synergizes with netrin-1 to drive persistent firing in the entorhinal cortex
2024, Cell Reports
The ability of the mammalian brain to maintain spatial representations of external or internal information for short periods of time has been associated with sustained neuronal spiking and reverberatory neural network activity in the medial entorhinal cortex. Here, we show that conditional genetic deletion of netrin-1 or the netrin receptor deleted-in-colorectal cancer (DCC) from forebrain excitatory neurons leads to deficits in short-term spatial memory. We then demonstrate that conditional deletion of either netrin-1 or DCC inhibits cholinergic persistent firing and show that cholinergic activation of muscarinic receptors expressed by entorhinal cortical neurons promotes persistent firing by recruiting DCC to the plasma membrane. Together, these findings indicate that normal short-term spatial memory function requires the synergistic actions of acetylcholine and netrin-1.
Acetylcholine and metacognition during sleep
2024, Consciousness and Cognition
Acetylcholine is a neurotransmitter and neuromodulator involved in a variety of cognitive functions. Additionally, acetylcholine is involved in the regulation of REM sleep: cholinergic neurons in the brainstem and basal forebrain project to and innervate wide areas of the cerebral cortex, and reciprocally interact with other neuromodulatory systems, to produce the sleep-wake cycle and different sleep stages. Consciousness and cognition vary considerably across and within sleep stages, with metacognitive capacity being strikingly reduced even during aesthetically and emotionally rich dream experiences. A notable exception is the phenomenon of lucid dreaming—a rare state whereby waking levels of metacognitive awareness are restored during sleep—resulting in individuals becoming aware of the fact that they are dreaming. The role of neurotransmitters in these fluctuations of consciousness and cognition during sleep is still poorly understood. While recent studies using acetylcholinesterase inhibitors suggest a potential role of acetylcholine in the occurrence of lucid dreaming, the underlying mechanisms by which this effect is produced remains un-modelled and unknown; with the causal link between cholinergic mechanisms and upstream psychological states being complex and elusive. Several theories and approaches targeting the association between acetylcholine and metacognition during wakefulness and sleep are highlighted in this review, moving through microscopic, mesoscopic and macroscopic levels of analysis to detail this phenomenon at several organisational scales. Several exploratory hypotheses will be developed to guide future research towards fully articulating how metacognition is affected by activity at the acetylcholine receptor.
Delayed cognitive impairments in a rat model of Gulf War Illness are stimulus-dependent
2023, Brain, Behavior, and Immunity
Gulf War Illness (GWI) collectively describes the multitude of central and peripheral disturbances affecting soldiers who served in the 1990–1991 Gulf War. While the mechanisms responsible for GWI remain elusive, the prophylactic use of the reversible acetylcholinesterase inhibitor, pyridostigmine bromide (PB), and war-related stress have been identified as chief factors in GWI pathology. Post-deployment stress is a common challenge faced by veterans, and aberrant cholinergic and/or immune responses to these psychological stressors may play an important role in GWI pathology, especially the cognitive impairments experienced by many GWI patients. Therefore, the current study investigated if an immobilization stress challenge would produce abnormal responses in PB-treated rats three months later. Results indicate that hippocampal cholinergic responses to an immobilization stress challenge are impaired three months after PB administration. We also assessed if an immune or stress challenge reveals deficits in PB-treated animals during hippocampal-dependent learning and memory tasks at this delayed timepoint. Novel object recognition (NOR) testing paired with either acute saline or lipopolysaccharide (LPS, 30 µg/kg, i.p.), as well as Morris water maze (MWM) testing was conducted approximately three months after PB administration and/or repeated restraint stress. Rats with a history of PB treatment exhibited 24-hour hippocampal-dependent memory deficits when challenged with LPS, but not saline, in the NOR task. Similarly, in the same cohort, PB-treated rats showed 24-hour memory deficits in the MWM task. Ultimately, these studies highlight the long-term effects of PB treatment on hippocampal function and provide insight into the progressive cognitive deficits observed in veterans with GWI.
Neurochemistry of sleep
2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
The control of sleep and wakefulness relies on reciprocal interactions across chemically distinct neuronal populations located throughout the brain. Within the brainstem, hypothalamus, and basal forebrain reside diverse sets of neurons that initiate and maintain wakefulness, while regions within the brainstem and hypothalamus contain sleep-promoting neurons. Together these sleep- and wake-promoting populations work in opposition to orchestrate sleep and wakefulness. In this chapter, we will review historical and contemporary perspectives on the neurobiology of sleep and wakefulness and highlight recent advances in genetic and imaging techniques that have helped to further define the regions, neurotransmitters, and substances that influence these dynamic behaviors.
Metabotropic glutamate receptor function and regulation of sleep-wake cycles
2023, International Review of Neurobiology
Metabotropic glutamate (mGlu) receptors are the most abundant family of G-protein coupled receptors and are widely expressed throughout the central nervous system (CNS). Alterations in glutamate homeostasis, including dysregulations in mGlu receptor function, have been indicated as key contributors to multiple CNS disorders. Fluctuations in mGlu receptor expression and function also occur across diurnal sleep-wake cycles. Sleep disturbances including insomnia are frequently comorbid with neuropsychiatric, neurodevelopmental, and neurodegenerative conditions. These often precede behavioral symptoms and/or correlate with symptom severity and relapse. Chronic sleep disturbances may also be a consequence of primary symptom progression and can exacerbate neurodegeneration in disorders including Alzheimer's disease (AD). Thus, there is a bidirectional relationship between sleep disturbances and CNS disorders; disrupted sleep may serve as both a cause and a consequence of the disorder. Importantly, comorbid sleep disturbances are rarely a direct target of primary pharmacological treatments for neuropsychiatric disorders even though improving sleep can positively impact other symptom clusters. This chapter details known roles of mGlu receptor subtypes in both sleep-wake regulation and CNS disorders focusing on schizophrenia, major depressive disorder, post-traumatic stress disorder, AD, and substance use disorder (cocaine and opioid). In this chapter, preclinical electrophysiological, genetic, and pharmacological studies are described, and, when possible, human genetic, imaging, and post-mortem studies are also discussed. In addition to reviewing the important relationships between sleep, mGlu receptors, and CNS disorders, this chapter highlights the development of selective mGlu receptor ligands that hold promise for improving both primary symptoms and sleep disturbances.

View all citing articles on Scopus

View full text

Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats

Abstract

Prog. Neurobiol.

Life Sci.

Life Sci.

Brain Res.

Neurosci. Lett.

Brain Res.

Neuroscience

Brain Res.